Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 7 Issue 12, December 2001

Editorial

Top of page ⤴

Letters to the Editor

Top of page ⤴

News

Top of page ⤴

Obituary

Top of page ⤴

Commentary

  • The anthrax attacks in the United States, juxtaposed against the September 11 terrorist attacks on New York and Washington, DC, have transformed a theoretical threat to stark reality. The biomedical research community will be an integral part of the preparation for, defense against and response to bioterrorism

    • H. Clifford Lane
    • John La Montagne
    • Anthony S. Fauci
    Commentary
Top of page ⤴

Book Review

Top of page ⤴

News & Views

  • Cardiomyocyte apoptosis occurs during reperfusion injury, transplant rejection and heart failure. The ability to image apoptosis non-invasively in the intact heart could lead to a more precise assessment of the clinical condition of patients, and could also expedite therapy. (pages 1347–1352 and 1352–1355)

    • Roberta A. Gottlieb
    • Richard N. Kitsis
    News & Views
  • In a healthy cell, the normal business of Tsg101 protein is as part of the machinery for protein trafficking. It now emerges that two deadly but unrelated viruses, HIV-1 and Ebola, both subvert Tsg101 as an essential step in their life cycles—exiting a cell to restart the cycle of infection. (pages 1313–1319)

    • Jeremy Luban
    News & Views
  • The intriguing finding that α-synuclein—a protein recently found to be mutated in some familial cases of Parkinson disease—and cytosolic dopamine interact to form adducts that stabilize a presumably toxic intermediate of fibril formation provides clues into the mechanism of neurodegeneration.

    • David Sulzer
    News & Views
  • Reduction in blood levels of low-density lipoprotein cholesterol reduces the risk of coronary heart disease. The identification of a new class of compounds that upregulate the low-density lipoprotein receptor may lead to new therapeutic advances. (pages 1332–1338)

    • Daniel J. Rader
    News & Views
  • Over time, bacteria have evolved mechanisms to enable them to outwit the efforts of their host to destroy them. New studies have uncovered a hitherto unknown mechanism of defense used by one of the commonest bacteria to infect humans, and a major pathogen, group A Streptococcus (pages 1298–1305)

    • Michael M. Frank
    News & Views
  • The identification of a new influenza virus protein PB1-F2, which localizes to mitochondria and causes cell death, may offer important insights into pathogenicity, as well as providing another example of how the virus can expand the coding capacity of its genome using overlapping reading frames. (pages 1306–1312)

    • Robert A. Lamb
    • Makoto Takeda
    News & Views
  • Ouabain signaling through a plasma membrane can produce oscillations of intracellular calcium levels, resulting in translocation of the NF-κB transcription factor into the nucleus and gene activation. This is a previously unrecognized form of steroid action.

    • Georgios Scheiner-Bobis
    • Wilhelm Schoner
    News & Views
Top of page ⤴

Article

Top of page ⤴

On the Market

Top of page ⤴

Search

Quick links